Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Theoretical Approaches to Psychological Disorder01:29

Theoretical Approaches to Psychological Disorder

The development of psychological disorders, which are characterized by deviant, maladaptive, and personally distressing behaviors, has been explored through several theoretical approaches.
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An implementation "Field Trial" of DBT for adolescents with bipolar disorder: Training procedures and therapist outcomes.

Journal of affective disorders·2026
Same author

Prediction modeling in transdiagnostic risk: results from the PROCAN study.

Brain imaging and behavior·2026
Same author

Polygenic Risk for Insomnia in Relation to Sleep Disturbance and Psychiatric Characteristics in Youth with Mood Disorders.

Journal of child and adolescent psychopharmacology·2026
Same author

Advancing Brain and Body Vascular Imaging in Bipolar Disorder: A Report From the International Society for Bipolar Disorders Vascular Task Force.

Bipolar disorders·2026
Same author

An evaluation of the clinician-facing research dashboards from the Toronto Adolescent and Youth (TAY) Cohort Study in mental health care.

PLOS mental health·2026
Same author

Pilot Trial of Adjunctive Curcumin for Treatment-Resistant Bipolar Depression in Youth: Focus on Inflammation and Oxidative Stress.

Journal of child and adolescent psychopharmacology·2026
Same journal

Physical Activity Awareness of British Adolescents.

Archives of pediatrics & adolescent medicine·2013
Same journal

About this journal.

Archives of pediatrics & adolescent medicine·2013
Same journal

Picture of the month-diagnosis.

Archives of pediatrics & adolescent medicine·2013
Same journal

Picture of the month-diagnosis.

Archives of pediatrics & adolescent medicine·2013
Same journal

Puget sound, Seattle, washington. March 2006.

Archives of pediatrics & adolescent medicine·2013
Same journal

Talia's shell, July 2008, in Bay Head, New Jersey.

Archives of pediatrics & adolescent medicine·2013
See all related articles

Related Experiment Video

Updated: May 26, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Recent progress in understanding pediatric bipolar disorder.

Benjamin I Goldstein1

  • 1Department of Psychiatry, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, FG53, Toronto, ON M4N 3M5, Canada. benjamin.goldstein@sunnybrook.ca

Archives of Pediatrics & Adolescent Medicine
|January 4, 2012
PubMed
Summary
This summary is machine-generated.

Bipolar disorder in youth presents significant challenges, including functional impairment and suicidality. Accurate diagnosis and treatment are crucial to avoid misdiagnosis and ensure effective care for children and adolescents.

Related Experiment Videos

Last Updated: May 26, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

  • Child and Adolescent Psychiatry
  • Neuroscience
  • Psychiatric Epidemiology

Background:

  • Bipolar disorder is a severe psychiatric illness with significant implications when it emerges in childhood or adolescence.
  • The focus has shifted from the existence to the prevalence of pediatric bipolar disorder.
  • Misdiagnosing or undertreating bipolar disorder carries substantial risks.

Purpose of the Study:

  • To review the current understanding of bipolar disorder in children and adolescents.
  • To address concerns regarding diagnostic accuracy and treatment efficacy.
  • To highlight the complexities of managing pediatric bipolar disorder.

Main Methods:

  • Review of empirical evidence on pediatric bipolar disorder.
  • Analysis of diagnostic trends and epidemiological data.
  • Examination of treatment options, including pharmacotherapy and psychosocial interventions.

Main Results:

  • Pediatric bipolar disorder shares characteristics with adult-onset illness, including recurrence, functional impairment, suicidality, and comorbidities.
  • Discrepancies exist between billing diagnoses and prevalence, suggesting inconsistent application of diagnostic criteria.
  • Second-generation antipsychotics show efficacy for manic episodes, while psychosocial treatments aid in managing depressive symptoms and educating families.

Conclusions:

  • Accurate diagnosis and systematic application of criteria are vital for pediatric bipolar disorder.
  • Psychosocial interventions are beneficial for depressive symptoms and family education.
  • Biomarkers hold future promise for diagnostic and treatment decisions in pediatric bipolar disorder.